Aurinia Pharmaceuticals Inc.

AUPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.61

-$0.29 (-1.72%)

At close: Sep 21, 2026, 4:00 PM ET

$16.69

+$0.08 (+0.48%)

Pre-market: Sep 22, 2026, 7:06 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.14B

Enterprise Value $1.75B

Beta 1.41

Average Volume 1.37M

Shares Outstanding (Diluted) 133.53M

Shares Change YoY -6.75%

Institutional Ownership 55.91%

Exchange NASDAQ

ISIN CA05156V1022

Price Performance

Price Change 1M 0.0%

Price Change 3M -7.1%

Price Change 6M 15.6%

Price Change YTD 8.2%

Price Change 1Y 27.1%

Price Change 3Y 98.9%

Price Change 5Y -28.5%

1M CAGR (ann.) 4.8%

1Y CAGR (ann.) 28.9%

5Y CAGR (ann.) -4.5%

All-Time CAGR 12.8%

Valuation

PE Ratio 7.25

Forward PE 13.13

PEG Ratio 0.02

Forward PEG 0.28

PS Ratio 6.86

Forward PS 5.50

PB Ratio 3.47

P/FCF Ratio 10.34

P/Adj. FCF Ratio 10.71

P/OCF Ratio 12.40

EV/Sales 5.63

EV/EBIT 10.39

EV/EBITDA 9.32

EV/FCF 8.49

Earnings Yield 13.8%

FCF Yield 9.7%

Adj. FCF Yield 9.3%

Financial Health

Net Cash $443.12M

Total Debt $60.42M

Cash & Short-Term Investments $443.12M

Total Assets $792.26M

Current Ratio 5.42

Quick Ratio 4.97

Debt / Equity Ratio 0.10

Debt / EBITDA 0.32

Debt / FCF 0.29

OCF / Debt 3.42

Interest Coverage 17.79

Altman Z-Score 7.97

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 90.4%

Operating Profit Margin 48.4%

EBITDA Margin 60.4%

Net Profit Margin 100.8%

FCF Margin 66.3%

Adj. FCF Margin 64.0%

SBC / Revenue 2.5%

SBC Impact (per share) -3.4%

Returns

Return on Assets 39.6%

Return on Equity 59.0%

Return on Invested Capital 21.3%

Return on Capital Employed 21.8%

Return on Tangible Assets 39.8%

Historical Growth (CAGR)

Revenue CAGR 3Y 24.8%

Revenue CAGR 5Y 40.2%

Revenue CAGR 10Y 106.0%

EPS CAGR 3Y 167.8%

EPS CAGR 5Y 558.6%

EPS CAGR 10Y 59.1%

FCF CAGR 3Y 105.2%

FCF CAGR 5Y 357.8%

FCF CAGR 10Y 95.5%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 15

EPS Growth Next 3Y -11.2%

Revenue Growth Next 3Y 14.8%

Earnings Date Nov 2, 2026

EPS Estimate (next Q) $0.21

EPS Growth Est (next Q) -8.7%

Revenue Est (next Q) $83.61M

Revenue Growth Est (next Q) 13.8%

Fair Value Estimates

Graham Number $15.61

Graham Upside -6.0%

Lynch Fair Value $57.25

Lynch Upside 244.7%

Price Target $16

Price Target Upside -3.7%

Cash Flow

Operating Cash Flow $206.71M

Free Cash Flow $206.49M

Adj. Free Cash Flow $199.47M

FCF Per Share $1.33

OCF Per Share $1.34

OCF/S Ratio 55.8%

Income Statement

Revenue $311.51M

Gross Profit $281.47M

Operating Income $150.75M

EBITDA $188.22M

Net Income $314.11M

EPS (Diluted) $2.29

Revenue / Employee $2.43M

Profit / Employee $2.45M

Employees 128